Skip to content

Search for intracranial vascular abnormalities in Coates' disease and disease-causing genes by whole exome sequencing analysis

Search for intracranial vascular abnormalities in Coates' disease and disease-causing genes by whole exome sequencing analysis - Search for intracranial vascular abnormalities in Coates' disease and disease-causing genes by whole exome sequencing analysis

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
JPRN
Registry ID
JPRN-UMIN000045672
Enrollment
24
Registered
2021-10-12
Start date
2021-10-18
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Coat&#39

Interventions

Head MRI scan / collecting blood(5ml)

Sponsors

Gunma university
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Patients diagnosed with Coats disease (Shields staging system is used for diagnosis. All stages of the disease are included.) Patients aged 11 years and older (regardless of gender). Outpatients.Patients who have given written consent to participate in this study.

Exclusion criteria

Exclusion criteria: (1) Patients with contraindications to MRI examinations at Josai Clinic (2) Patients with non-MRI compatible devices such as cardiac pacemakers, stimulation electrodes, cochlear implants, or artificial middle ears. (3) Patients who have undergone surgery such as vascular stenting or old valve replacement surgery that is not MRI compatible. (4) Patients with metal implants such as cerebral artery clips or artificial joints in the body that do not support MRI (5) Pregnant women (6) Patients with tattoos (7) Patients with a history of epilepsy (Loud noises may induce epileptic seizures in rare cases) (8) Those who are claustrophobic or otherwise uncomfortable in confined spaces, or who are sensitive to loud noises (9) Patients who are judged by their physicians to be unsuitable for the program.

Design outcomes

Primary

MeasureTime frame
Prevalence of cerebrovascular abnormalities on MRI

Secondary

MeasureTime frame
Detection rate of RNF213 gene mutation Identification of disease-causing gene mutations

Countries

Japan

Contacts

Public ContactHideo Akiyama

Gunma university Ophthalmology

akiyamah47@gunma-u.ac.jp0272208338

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026